Transcriptional profiling of such a large cohort of a single molecular type of cancer allows for a thorough understanding of the tumor’s genomic landscape, including the identification of genes affected by mutations (GNAS, MYCN, PPM1D, and PRKAR1A), and fusion transcripts (ZBTB20 and NCOR1). The gene discussed is PRKAR1A; the disease is neoplasm.